Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis

JSK Teh, J Coussement, ZCF Neoh… - Blood …, 2022 - ashpublications.org
The objectives of this study were to assess the immunogenicity and safety of COVID-19
vaccines in patients with hematologic malignancies. A systematic review and meta-analysis …

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis

KL Chai, J Wong, R Weinkove, A Keegan… - Blood …, 2023 - ashpublications.org
Acquired hypogammaglobulinemia is common in chronic lymphocytic leukemia (CLL), non-
Hodgkin lymphoma (NHL), and multiple myeloma (MM). No previous systematic reviews …

Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

LR Baden, S Swaminathan, NG Almyroudis… - Journal of the National …, 2024 - jnccn.org
There is an increased risk of infection in patients with cancer that results in higher morbidity
and mortality. Several risk factors can predispose these patients to infectious complications …

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies

A Mori, M Onozawa, S Tsukamoto… - British journal of …, 2022 - Wiley Online Library
Data on the response to the COVID‐19 vaccine in patients with myeloid malignancy, who
are at severe risk in case of infection, have not emerged. In a study of 69 patients with …

Vaccination of adults with cancer: ASCO guideline

M Kamboj, K Bohlke, DM Baptiste… - Journal of Clinical …, 2024 - ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Comparison of two high-dose versus two standard-dose influenza vaccines in adult allogeneic hematopoietic cell transplant recipients

LD Thomas, E Batarseh, L Hamdan… - Clinical Infectious …, 2023 - academic.oup.com
Background Adult hematopoietic cell transplant (HCT) recipients are at high risk for
influenza-related morbidity and mortality and have suboptimal influenza vaccine immune …

Vaccine challenges in CLL: A comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia

CN Kontandreopoulou, EE Solomou, E Kolorizos… - Annals of …, 2024 - Springer
Chronic lymphocytic leukemia (CLL) is characterized by disease-and treatment-related
immunosuppression. Patients with CLL comprise a vulnerable population to coronavirus …

Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis

AA Veroniki, SS Thirugnanasampanthar… - BMJ Evidence-Based …, 2024 - ebm.bmj.com
Objectives To compare the efficacy of influenza vaccines of any valency for adults 60 years
and older. Design and setting Systematic review with network meta-analysis (NMA) of …

Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy

THO Nguyen, C Lim, M Lasica, A Whitechurch… - …, 2023 - Wiley Online Library
Zanubrutinib‐treated and treatment‐naïve patients with chronic lymphocytic leukaemia
(CLL) or Waldenstrom's macroglobulinaemia were recruited in this prospective study to …

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural …

L Vigón, A Sánchez-Tornero… - Journal of Clinical …, 2022 - mdpi.com
Oncohematological patients show a low immune response against SARS-CoV-2, both to
natural infection and after vaccination. Most studies are focused on the analysis of the …